Teladoc Health Chief Innovation Officer Claus Jensen resigns; receives $743,750 separation

Teladoc Health, Inc.

Claus Jensen resigns as Chief Innovation Officer effective December 1, 2023.
Cash separation payment of $743,750 (6 months salary plus 75% of target 2023 bonus).
Accelerated vesting of time-based equity awards vesting on or before December 2, 2024.
Continued eligibility for performance-based awards through December 31, 2023.
Up to 6 months COBRA premium coverage; 12-month non-compete and non-solicit obligations.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Claus T. Jensen

Chief Innovation Officer

TDOC · Teladoc Health, Inc.

Effective: 2023-12-01
Filed: November 14, 2023, 6:59 PM ET

On November 8, 2023, Claus T. Jensen, PhD resigned as Chief Innovation Officer of Teladoc Health, Inc. (the “Company”), effective December 1, 2023 (the “Separation Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Claus T. Jensen resigned as Chief Innovation Officer at Teladoc Health, Inc..

Action: resigned
Role: Chief Innovation Officer

Exact text from the filing

On November 8, 2023, Claus T. Jensen, PhD resigned as Chief Innovation Officer of Teladoc Health, Inc. (the “Company”), effective December 1, 2023 (the “Separation Date”).

View on SEC.gov

Teladoc Health, Inc. filing history →

Source: SEC EDGAR

accession 0001477449-23-000076

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.